Evidence map›Paper›PMID 28082375›Full record

ArticleInternational journal of epidemiology2017

Evidence for large-scale gene-by-smoking interaction effects on pulmonary function.

Hugues Aschard, Martin D Tobin, Dana B Hancock, David Skurnik, Akshay Sood, Alan James, Albert Vernon Smith, Ani W Manichaikul, Archie Campbell, Bram P Prins and 42 more

Open access · bronzeAbstract read
In one paragraph

Article in International journal of epidemiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Tradeoffs in Modeling Context Dependency in Complex Trait Genetics.bioRxiv : the preprint server for biology · 2025
    Article
  6. Article
  7. Review
  8. A Polygenic Risk Score for Idiopathic Pulmonary Fibrosis and Interstitial Lung Abnormalities.American journal of respiratory and critical care medicine · 2023
    Article
  9. Article
  10. Article
  11. Gene-lifestyle interactions in the genomics of human complex traits.European journal of human genetics : EJHG · 2022
    Article
  12. Review
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

52 authors at 20 institutions in 10 countries.

Hugues AschardDepartment of Epidemiology, Harvard TH Chan School of Public Health, Boston, MA, USA.
Martin D TobinGenetic Epidemiology Group, Department of Health Sciences, University of Leicester, Leicester, UK.
Dana B HancockBehavioral and Urban Health Program, Behavioral Health and Criminal Justice Research Division, Research Triangle Institute (RTI) International, Research Triangle Park, NC, USA.
David SkurnikDivision of Infectious Diseases, Brigham and Women Hospital, Harvard Medical School, Boston, MA, USA.
Akshay SoodDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM, USA.
Alan JamesDepartment of Pulmonary Physiology and Sleep Medicine, Sir Charles Gairdner Hospital, Nedlands, Australia.
Albert Vernon SmithIcelandic Heart Association, Kopavogur, Iceland.
Ani W ManichaikulCenter for Public Health Genomics, University of Virginia, Charlottesville, VA, USA.
Archie CampbellCentre for Genomic & Experimental Medicine, Institute of Genetics & Molecular Medicine, University of Edinburgh, Edinburgh, UK.
Bram P PrinsDepartment of Human Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.
Caroline HaywardMRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.
Daan W LothDepartment of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
David J PorteousCentre for Genomic & Experimental Medicine, Institute of Genetics & Molecular Medicine, University of Edinburgh, Edinburgh, UK.
David P StrachanPopulation Health Research Institute, St George's University of London, London, UK.
Eleftheria ZegginiDepartment of Human Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.
George T O'ConnorThe National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, MA, USA.
Guy G BrusselleDepartment of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
H Marike BoezenUniversity of Groningen, University Medical Center Groningen, Department of Epidemiology, Groningen, The Netherlands.
Holger SchulzInstitute of Epidemiology I, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
Ian J DearyCentre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK.
Ian P HallDivision of Respiratory Medicine, University of Nottingham, Queen's Medical Centre, Nottingham, UK.
Igor RudanCentre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK.
Jaakko KaprioDepartment of Public Health, University of Helsinki, Helsinki, Finland.
James F WilsonMRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.
Jemma B WilkThe National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, MA, USA.
Jennifer E HuffmanMRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.
Jing Hua ZhaoMRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, UK.
Kim de JongUniversity of Groningen, University Medical Center Groningen, Department of Epidemiology, Groningen, The Netherlands.
Leo-Pekka LyytikäinenDepartment of Clinical Chemistry, Fimlab Laboratories, Tampere, Finland.
Louise V WainGenetic Epidemiology Group, Department of Health Sciences, University of Leicester, Leicester, UK.
Marjo-Riitta JarvelinDepartment of Epidemiology and Biostatistics, MRC-PHE Centre for Environment & Health, School of Public Health, Imperial College London, UK.
Mika KähönenDepartment of Clinical Physiology, University of Tampere and Tampere University Hospital, Tampere, Finland.
Myriam FornageBrown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA.
Ozren PolasekCentre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK.
Patricia A CassanoDivision of Nutritional Sciences, Cornell University, Ithaca, NY, USA.
R Graham BarrDepartments of Medicine and Epidemiology, Columbia University Medical Center.
Rajesh RawalInstitute of Genetic Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
Sarah E HarrisCentre for Genomic & Experimental Medicine, Institute of Genetics & Molecular Medicine, University of Edinburgh, Edinburgh, UK.
Sina A GharibComputational Medicine Core at Center for Lung Biology, Division of Pulmonary & Critical Care Medicine, University of Washington, Seattle, WA.
Stefan EnrothDepartment of Immunology, Genetics and Pathology, Uppsala Universitet, Science for Life Laboratory, Uppsala, Sweden.
Susan R HeckbertBoehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA.
Terho LehtimäkiDepartment of Clinical Chemistry, Fimlab Laboratories, Tampere, Finland.
Ulf GyllenstenDepartment of Immunology, Genetics and Pathology, Uppsala Universitet, Science for Life Laboratory, Uppsala, Sweden.
Understanding Society Scientific Group
Victoria E JacksonGenetic Epidemiology Group, Department of Health Sciences, University of Leicester, Leicester, UK.
Vilmundur GudnasonIcelandic Heart Association, Kopavogur, Iceland.
Wenbo TangDivision of Nutritional Sciences, Cornell University, Ithaca, NY, USA.
Josée DupuisThe National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, MA, USA.
María Soler ArtigasGenetic Epidemiology Group, Department of Health Sciences, University of Leicester, Leicester, UK.
Amit D JoshiDepartment of Epidemiology, Harvard TH Chan School of Public Health, Boston, MA, USA.
Stephanie J LondonEpidemiology Branch, National Institute of Environmental Health Sciences, National Institutes of Health, US Department of Health and Human Services, Research Triangle Park, NC, USA.
Peter KraftDepartment of Epidemiology, Harvard TH Chan School of Public Health, Boston, MA, USA.
University of Edinburgh · GBHarvard University · USBoehringer Ingelheim (United States) · USEdinburgh Cancer Research · GBErasmus MC · NLFramingham Heart Study · USHelmholtz Zentrum München · DEIcelandic Heart Association · ISNational Institute for Health Research · GBScience for Life Laboratory · SEUniversity of Groningen · NLUniversity of Leicester · GBWellcome Sanger Institute · GBBoston University · USBrown Foundation · USColumbia University Irving Medical Center · USCornell University · USFinnish Institute for Health and Welfare · FIImperial College London · GBInstitute of Genetics and Cancer · GB

Funding

Pulmonary microvascular perfusion in the Multi-Ethnic Study of AtherosclerosisR01HL077612 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI R Graham BARR · 2004 to 2026
$18.8M
Pulmonary Vascular Changes in Early Chronic Obstructive Pulmonary Disease (COPD)R01HL093081 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI R Graham BARR · 2008 to 2026
$17.2M
Genetics and Environment in Adult Respiratory, Allergic and Cardiac diseaseZIAES043012 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI LONDON, STEPHANIE · 2009 to 2025
$6.4M
Risk Prediction of Symptomatic Gallbladder DiseaseK01DK110267 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI JOSHI, AMIT DOLAR · 2016 to 2021
$876k
Identifying Genome-scale Interaction Effects in Human Traits and DiseasesR21HG007687 · NHGRI · HARVARD SCHOOL OF PUBLIC HEALTH · PI ASCHARD, HUGUES · 2015 to 2016
$444k
Biotechnology and Biological Sciences Research Council BB/F019394/1Chief Scientist Office CZD/16/6/4Medical Research Council G0902313Medical Research Council G1000861Medical Research Council MC_PC_12010Medical Research Council MC_PC_U127561128Medical Research Council MR/K026992/1Medical Research Council MR/N011317/1NHGRI NIH HHS R21 HG007687NHLBI NIH HHS R01 HL077612NHLBI NIH HHS R01 HL093081NIDDK NIH HHS K01 DK110267Wellcome Trust 202849/Z/16/Z
6 · The paper itself

Abstract

Background: Smoking is the strongest environmental risk factor for reduced pulmonary function. The genetic component of various pulmonary traits has also been demonstrated, and at least 26 loci have been reproducibly associated with either FEV 1 (forced expiratory volume in 1 second) or FEV 1 /FVC (FEV 1 /forced vital capacity). Although the main effects of smoking and genetic loci are well established, the question of potential gene-by-smoking interaction effect remains unanswered. The aim of the present study was to assess, using a genetic risk score approach, whether the effect of these 26 loci on pulmonary function is influenced by smoking. Methods: We evaluated the interaction between smoking exposure, considered as either ever vs never or pack-years, and a 26-single nucleotide polymorphisms (SNPs) genetic risk score in relation to FEV 1 or FEV 1 /FVC in 50 047 participants of European ancestry from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) and SpiroMeta consortia. Results: We identified an interaction ( βint  = -0.036, 95% confidence interval, -0.040 to -0.032, P  = 0.00057) between an unweighted 26 SNP genetic risk score and smoking status (ever/never) on the FEV 1 /FVC ratio. In interpreting this interaction, we showed that the genetic risk of falling below the FEV /FVC threshold used to diagnose chronic obstructive pulmonary disease is higher among ever smokers than among never smokers. A replication analysis in two independent datasets, although not statistically significant, showed a similar trend in the interaction effect. Conclusions: This study highlights the benefit of using genetic risk scores for identifying interactions missed when studying individual SNPs and shows, for the first time, that persons with the highest genetic risk for low FEV 1 /FVC may be more susceptible to the deleterious effects of smoking.

Indexed as

Gene-Environment InteractionEuropeFemaleForced Expiratory VolumeHumansLinear ModelsMaleMiddle AgedMultivariate AnalysisPolymorphism, Single NucleotideRisk AssessmentSmokingSpirometryVital CapacityFEV1/FVCgene–environment interactiongenetic risk scoresmoking

Identifiers

PMID28082375
PMCPMC5837518
OpenAlexW2548616668

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.